David A. Ingram

13.7k citations

119 papers · 10.3k · 4 hit papers · h-index 46

Impact in

Genetics top 0.2%
- Mesenchymal stem cell research
Neurology top 0.5%
- Neurofibromatosis and Schwannoma Cases

Papers in

Molecular Biology 55
- Angiogenesis and VEGF in Cancer 36
- Congenital heart defects research 10
Neurology 27
- Neurofibromatosis and Schwannoma Cases 23
- Neuroblastoma Research and Treatments 6

Co-authors: Mervin C. Yöder (33 shared papers)Laura E. Mead (22 shared papers)Daniel N. Prater (10 shared papers)Jamie Case (19 shared papers)Karen K. Hirschi (1 shared paper)Fang Li (2 shared papers)Karen E. Pollok (2 shared papers)David Gilley (2 shared papers)
Journals: Blood (20 papers)Journal of Clinical Investigation (5 papers)Muscle & Nerve (5 papers)Pediatric Research (4 papers)Experimental Hematology (4 papers)
Partner nations: United States United Kingdom India

In The Last Decade

David A. Ingram

119 papers receiving 10.1k citations

David A. Ingram's Hit Papers

align trajectories log scale

Early Pulmonary Vascular Disease in Preterm Infants at Risk for Bronchopulmonary Dysplasia 2014 · 329 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 American Journal of Respiratory and Critical Care Medicine
2008 Arteriosclerosis Thrombosis and Vascular Biology
2006 Blood
2004 Blood

Peers

Countries citing papers authored by David A. Ingram

Since Specialization

Citations

This map shows the geographic impact of David A. Ingram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Ingram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Ingram more than expected).

Fields of papers citing papers by David A. Ingram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Ingram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Ingram. The network helps show where David A. Ingram may publish in the future.

Co-authors

The 25 scholars most cited alongside David A. Ingram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. Ingram Line = papers co-authored together David A. Ingram links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood Blood ·David A. Ingram, Laura E. Mead, Hiromi Tanaka, Virginia M. Meade, Amy Fenoglio, Kelly E. Mortell, Karen E. Pollok, Michael J. Ferkowicz, David Gilley, Mervin C. Yöder Hit paper breakdown →	2004	1217
2	Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood ·Mervin C. Yöder, Laura E. Mead, Daniel N. Prater, Theresa R. Krier, Karim N. Mroueh, Fang Li, Rachel Krasich, Constance J. Temm, Josef T. Prchal, David A. Ingram Hit paper breakdown →	2006	1154
3	Assessing Identity, Phenotype, and Fate of Endothelial Progenitor Cells Arteriosclerosis Thrombosis and Vascular Biology ·Karen K. Hirschi, David A. Ingram, Mervin C. Yöder Hit paper breakdown →	2008	589
4	Vessel wall–derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells Blood ·David A. Ingram, Laura E. Mead, Daniel B. Moore, Wayne Woodard, Amy Fenoglio, Mervin C. Yöder	2004	449
5	Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors Experimental Hematology ·Jamie Case, Laura E. Mead, Waylan Bessler, Daniel N. Prater, Hilary White, M. Reza Saadatzadeh, Janak R. Bhavsar, Mervin C. Yöder, Laura S. Haneline, David A. Ingram	2007	412
6	Endothelial progenitor cells: identity defined? Journal of Cellular and Molecular Medicine ·Frank Timmermans, Jean Plum, Mervin C. Yöder, David A. Ingram, Bart Vandekerckhove, Jamie Case	2008	384
7	Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells Blood ·David A. Ingram, Noel M. Caplice, Mervin C. Yöder	2005	335
8	Early Pulmonary Vascular Disease in Preterm Infants at Risk for Bronchopulmonary Dysplasia American Journal of Respiratory and Critical Care Medicine ·Peter M. Mourani, Marci K. Sontag, Adel K. Younoszai, Josh Miller, John P. Kinsella, Christopher D. Baker, Brenda B. Poindexter, David A. Ingram, Steven H. Abman Hit paper breakdown →	2014	329
9	Robust Functional Vascular Network Formation In Vivo by Cooperation of Adipose Progenitor and Endothelial Cells Circulation Research ·Dmitry O. Traktuev, Daniel N. Prater, Stephanie Merfeld‐Clauss, Aravind Sanjeevaiah, M. Reza Saadatzadeh, Michael P. Murphy, Brian H. Johnstone, David A. Ingram, Keith L. March	2009	274
10	Periostin Is Required for Maturation and Extracellular Matrix Stabilization of Noncardiomyocyte Lineages of the Heart Circulation Research ·Paige Snider, Robert B. Hinton, Ricardo A. Moreno‐Rodriguez, Jian Wang, Rhonda Rogers, Andrew Lindsley, Fang Li, David A. Ingram, Donald R. Menick, Loren J. Field, Anthony B. Firulli, Jeffery D. Molkentin, Roger R. Markwald, Simon J. Conway	2008	271
11	Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow Cell ·Feng‐Chun Yang, David A. Ingram, Shi Chen, Yuan Zhu, Jin Yuan, Xiaohong Li, Xianlin Yang, Scott M. Knowles, Whitney Horn, Yan Li, Shaobo Zhang, Yanzhu Yang, Saeed T. Vakili, Menggang Yu, Dennis K. Burns, Kent A. Robertson, Gary D. Hutchins, Luis F. Parada, D. Wade Clapp	2008	249
12	Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/– mast cells Journal of Clinical Investigation ·Fengchun Yang, David A. Ingram, Shi Chen, Cynthia M. Hingtgen, Nancy Ratner, Kelly R. Monk, Travis Clegg, Hilary White, Laura E. Mead, Mary Jo Wenning, David A. Williams, Reuben Kapur, Simon J. Atkinson, D. Wade Clapp	2003	170
13	Plasticity of central motor pathways in children with hemiplegic cerebral palsy Neurology ·Simon F. Farmer, Linda M. Harrison, David A. Ingram, John A. Stephens	1991	169
14	Suppression of Hepatocyte Growth Factor Production Impairs the Ability of Adipose-Derived Stem Cells to Promote Ischemic Tissue Revascularization Stem Cells ·Liying Cai, Brian H. Johnstone, Todd Cook, (unknown), Dmitry O. Traktuev, Kenneth Cornetta, David A. Ingram, Elliot D. Rosen, Keith L. March	2007	163
15	Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo The Journal of Experimental Medicine ·David A. Ingram, Feng‐Chun Yang, Jeffrey B. Travers, Mary Jo Wenning, Kelly Hiatt, Sheryl New, Antoinette F. Hood, Kevin Shannon, David A. Williams, D. Wade Clapp	2000	155
16	In Vitro Hyperglycemia or a Diabetic Intrauterine Environment Reduces Neonatal Endothelial Colony-Forming Cell Numbers and Function Diabetes ·David A. Ingram, Izlin Lien, Laura E. Mead, Myka L. Estes, Daniel N. Prater, Ethel Derr‐Yellin, Linda A. DiMeglio, Laura S. Haneline	2007	135
17	Clinical significance of monocyte heterogeneity Clinical and Translational Medicine ·Brian K. Stansfield, David A. Ingram	2015	134
18	Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants American Journal of Respiratory and Critical Care Medicine ·Lindsey Morrow, Brandie D. Wagner, David A. Ingram, Brenda B. Poindexter, Kurt Schibler, C. Michael Cotten, John M. Dagle, Marci K. Sontag, Peter M. Mourani, Steven H. Abman	2017	128
19	Nf1+/− mast cells induce neurofibroma like phenotypes through secreted TGF-β signaling Human Molecular Genetics ·Feng‐Chun Yang, Chen Shi, Travis Clegg, Xiaohong Li, Trent Morgan, Selina A. Estwick, Jin Yuan, Waleed Khalaf, Sarah J. Burgin, Jeffrey B. Travers, Luis F. Parada, David A. Ingram, D. Wade Clapp	2006	123
20	Flow Cytometric Identification and Functional Characterization of Immature and Mature Circulating Endothelial Cells Arteriosclerosis Thrombosis and Vascular Biology ·Julie A. Mund, Myka L. Estes, Mervin C. Yöder, David A. Ingram, Jamie Case	2012	115

About David A. Ingram

David A. Ingram is a scholar working on Molecular Biology, Neurology, Immunology, Pulmonary and Respiratory Medicine and Oncology, having authored 119 papers that have together received 10.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (36 papers), Neurofibromatosis and Schwannoma Cases (23 papers), Congenital heart defects research (10 papers), Neonatal Respiratory Health Research (9 papers), Mesenchymal stem cell research (7 papers), Zebrafish Biomedical Research Applications (7 papers), Mast cells and histamine (7 papers) and Neuroblastoma Research and Treatments (6 papers). The work is most often cited by research in Genetics (1.6k citations), Neurology (1.3k citations), Molecular Biology (4.9k citations), Cancer Research (969 citations) and Pulmonary and Respiratory Medicine (1.6k citations). David A. Ingram has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Mervin C. Yöder, Laura E. Mead, Daniel N. Prater, Jamie Case, Karen K. Hirschi, Fang Li, Karen E. Pollok, David Gilley, Hiromi Tanaka and Kelly E. Mortell. Their work appears in journals such as Blood, Journal of Clinical Investigation, Muscle & Nerve, Pediatric Research and Experimental Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

David A. Ingram

Impact in

Papers in i

In The Last Decade

David A. Ingram

David A. Ingram's Hit Papers

Peers

Countries citing papers authored by David A. Ingram

Fields of papers citing papers by David A. Ingram

All Works

About David A. Ingram

Explore authors with similar magnitude of impact

Papers in